Literature DB >> 7333329

The kinetics of the urinary excretion of the N-oxide and glucuronides of methaqualone in man.

K Wilson, D Burnett, M Oram, C T Reynolds.   

Abstract

The urinary excretion of the N-oxide and the glucuronides of five C-monohydroxy metabolites of methaqualone has been studied following the oral administration of a single dose of the drug. The apparent first order rate constants for the excretion of each metabolite (kme) were shown to be numerically smaller than the overall elimination rate constant for methaqualone (k10). The Kme values tended to be greater than or equal to the corresponding apparent first order rate constants for the formation of the metabolite (km) but corresponding kme and km values were always of the same order magnitude. The kme values for the glucuronides were much smaller than the literature kme value for paracetemol glucuronide. The rate of renal elimination of the metabolites was variably sensitive to urine flow but over a period of time of 8 hours or greater the total amount of metabolite recovered in the urine was was independent of the total urine volume.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7333329     DOI: 10.1007/BF03189528

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  20 in total

1.  Polymorphism of carbon oxidation of drugs and clinical implications.

Authors:  T P Sloan; A Mahgoub; R Lancaster; J R Idle; R L Smith
Journal:  Br Med J       Date:  1978-09-02

2.  Metabolism of methaqualone by the epoxide-diol pathway in man and the rat.

Authors:  W G Stillwell; P A Gregory; M G Horning
Journal:  Drug Metab Dispos       Date:  1975 Jul-Aug       Impact factor: 3.922

3.  Urinary excretion pattern of methaqualone metabolites in man.

Authors:  O Ericsson; B Danielsson
Journal:  Drug Metab Dispos       Date:  1977 Nov-Dec       Impact factor: 3.922

4.  Methaqualone pharmacokinetics after single- and multiple-dose administration in man.

Authors:  R K Nayak; R D Smyth; J H Chamberlain; A Polk; A F DeLong; T Herczeg; P B Chemburkar; R S Joslin; N H Reavey-Cantwell
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

5.  Plasma concentrations and effects of methaqualone after single and multiple oral doses in man.

Authors:  G Alván; O Ericsson; S Levander; J E Lindgren
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

6.  Identification of free and conjugated metabolites of methaqualone by gas chromatography-mass spectrometry.

Authors:  R Bonnichsen; Y Mårde; R Ryhage
Journal:  Clin Chem       Date:  1974-02       Impact factor: 8.327

7.  Treatment of data from drug urinary excretion.

Authors:  B K Martin
Journal:  Nature       Date:  1967-04-15       Impact factor: 49.962

8.  Kinetic considerations relating to the accrual and elimination of drug metabolites.

Authors:  A J Cummings; B K Martin; G S Park
Journal:  Br J Pharmacol Chemother       Date:  1967-02

9.  Urinary excretion of methaqualone-N-oxide in man.

Authors:  C N Reynolds; K Wilson; D Burnett
Journal:  Xenobiotica       Date:  1976-02       Impact factor: 1.908

10.  The metabolism of methaqualone in patients with biliary cirrhosis or secondary carcinoma of the liver.

Authors:  D Burnett; C N Reynolds; K Wilson
Journal:  Eur J Clin Pharmacol       Date:  1979-02-19       Impact factor: 2.953

View more
  2 in total

1.  The effect of age on the competitive C- and N-oxidative pathways of methaqualone in women.

Authors:  K Wilson; M Oram; D Burnett
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Oct-Dec       Impact factor: 2.441

2.  The influence of the menstrual cycle on the metabolism and clearance of methaqualone.

Authors:  K Wilson; M Oram; C E Horth; D Burnett
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.